Epsilon M&A Deal Report - Euticals

Transaction Multiples for the Valuation of Private Companies

Private Group led by Clessidra, Idea Capital Funds and Private Equity Partners > Euticals

Announced Date : 28 February 2012

Type : SBO (Secondary Buy Out) ,Exit

Deal Value : Yes

Acquirer : Private Group led by Clessidra, Idea Capital Funds and Private Equity Partners

Target: Euticals

Target Country: Italy

Sector of activity : Health, Pharmaceuticals & Biotechnology, Chemicals

Business Description :

> Established in 1984, Euticals is a chemical company focused on Active Pharmaceutical Ingredient ...

No EMAT : 48215

Transaction multiples available

	EV/Sales	EV/Gross Profit	EV/EBITDA	EV/EBIT	Eq/PBT	P/E	Price to Book
Historic
Current

: Multiple available

n.s : Multiple calculated, but not significant

Rating *

Source: Epsilon Research / EMAT

Comparable Transactions

Number of EMAT Reports : (Chemicals) = 298

Example of comparable transactions on EMAT (same sub-sector):

Date	Acquirer	Target	Country	Multiples	See details
20/10/2010	Zaklady Azotowe w Tarnowie - Moscicach	Zaklady Azotowe Kedzierzyn (ZAK)	Poland	**
06/03/2012	Private Group Led by Arsenal Capital Partners	Global Colorants Business of Evonik Industries	Netherlands	*

Source: Epsilon Research / EMAT

View Report

This report is accessible on EMAT, the reference database for private company acquisition multiples

Example of EMAT Report : click here

View Complete Report

About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

Sectors covered by our analysts

Studies & indices published by Epsilon Research Register to receive (free) publications updates

EMAT Report

Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).

Subscribe to EMAT database